Comparison of Clinical Presentations and Outcomes Between Patients With TGFBR2 and FBN1 Mutations in Marfan Syndrome and Related Disorders
- 22 December 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 120 (25), 2541-2549
- https://doi.org/10.1161/circulationaha.109.887042
Abstract
Background— TGFBR2 mutations were recognized recently among patients with a Marfan-like phenotype. The associated clinical and prognostic spectra remain unclear. Methods and Results— Clinical features and outcomes of 71 patients with a TGFBR2 mutation (TGFBR2 group) were compared with 50 age- and sex-matched unaffected family members (control subjects) and 243 patients harboring FBN1 mutations (FBN1 group). Aortic dilatation was present in a similar proportion of patients in both the TGFBR2 and FBN1 groups (78% versus 79%, respectively) but was highly variable. The incidence and average age for thoracic aortic surgery (31% versus 27% and 35±16 versus 39±13 years, respectively) and aortic dissection (14% versus 10% and 38±12 versus 39±9 years) were also similar in the 2 groups. Mitral valve involvement (myxomatous, prolapse, mitral regurgitation) was less frequent in the TGFBR2 than in the FBN1 group (all P TGFBR2 mutations, versus 32% with FBN1 mutations ( P =0.002). The rate of death was greater in TGFBR2 families before diagnosis but similar once the disease had been recognized. Most pregnancies were uneventful (without death or aortic dissection) in both TGFBR2 and FBN1 families (38 of 39 versus 213 of 217; P =1). Seven patients (10%) with a TGFBR2 mutation fulfilled international criteria for Marfan syndrome, 3 of whom presented with features specific for Loeys-Dietz syndrome. Conclusions— Clinical outcomes appear similar between treated patients with TGFBR2 mutations and individuals with FBN1 mutations. Prognosis depends on clinical disease expression and treatment rather than simply the presence of a TGFBR2 gene mutation.This publication has 25 references indexed in Scilit:
- Human Splicing Finder: an online bioinformatics tool to predict splicing signalsNucleic Acids Research, 2009
- UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity-application to four genes:FBN1,FBN2,TGFBR1, andTGFBR2Human Mutation, 2009
- Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24–32 mutationEuropean Journal of Human Genetics, 2008
- A new locus-specific database (LSDB) for mutations in theTGFBR2gene: UMD-TGFBR2Human Mutation, 2007
- Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International StudyAmerican Journal of Human Genetics, 2007
- Severe aortic and arterial aneurysms associated with a TGFBR2 mutationNature Clinical Practice Cardiovascular Medicine, 2007
- Aneurysm Syndromes Caused by Mutations in the TGF-β ReceptorThe New England Journal of Medicine, 2006
- Clinical features in a family with an R460H mutation in transforming growth factor receptor 2 geneJournal of Medical Genetics, 2006
- Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defectsEuropean Journal of Human Genetics, 2005
- Two-dimensional echocardiographic aortic root dimensions in normal children and adultsThe American Journal of Cardiology, 1989